M.D.C. Holdings, Inc. (NYSE:MDC) Director Herbert T. Buchwald sold 4,644 shares of M.D.C. stock in a transaction that occurred on Tuesday, March 13th. The stock was sold at an average price of $29.84, for a total transaction of $138,576.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Herbert T. Buchwald also recently made the following trade(s):

How to Become a New Pot Stock Millionaire
  • On Friday, December 15th, Herbert T. Buchwald sold 28,350 shares of M.D.C. stock. The stock was sold at an average price of $31.52, for a total transaction of $893,592.00.

M.D.C. Holdings, Inc. (NYSE MDC) traded down $0.90 during mid-day trading on Wednesday, reaching $28.80. 222,397 shares of the company were exchanged, compared to its average volume of 804,424. The firm has a market cap of $1,587.73, a PE ratio of 10.66, a PEG ratio of 0.60 and a beta of 1.47. The company has a quick ratio of 3.34, a current ratio of 10.01 and a debt-to-equity ratio of 0.78. M.D.C. Holdings, Inc. has a one year low of $26.94 and a one year high of $37.45.

M.D.C. (NYSE:MDC) last released its earnings results on Thursday, February 1st. The construction company reported $0.43 EPS for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.25). The company had revenue of $704.26 million during the quarter, compared to analyst estimates of $722.48 million. M.D.C. had a return on equity of 11.00% and a net margin of 5.50%. The firm’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter last year, the business earned $0.78 earnings per share. sell-side analysts anticipate that M.D.C. Holdings, Inc. will post 2.99 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 21st. Investors of record on Wednesday, February 7th were paid a $0.30 dividend. The ex-dividend date of this dividend was Tuesday, February 6th. This is a boost from M.D.C.’s previous quarterly dividend of $0.25. This represents a $1.20 dividend on an annualized basis and a yield of 4.17%. M.D.C.’s dividend payout ratio (DPR) is 48.10%.

A number of hedge funds have recently added to or reduced their stakes in the stock. CVentures Inc. acquired a new stake in M.D.C. in the 4th quarter worth approximately $233,531,000. BlackRock Inc. boosted its stake in M.D.C. by 11.2% in the 4th quarter. BlackRock Inc. now owns 6,564,388 shares of the construction company’s stock worth $209,273,000 after purchasing an additional 660,834 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in M.D.C. by 0.6% in the 3rd quarter. Dimensional Fund Advisors LP now owns 4,364,077 shares of the construction company’s stock worth $144,930,000 after purchasing an additional 26,295 shares in the last quarter. Hamlin Capital Management LLC boosted its stake in M.D.C. by 6.6% in the 4th quarter. Hamlin Capital Management LLC now owns 1,195,187 shares of the construction company’s stock worth $38,103,000 after purchasing an additional 73,535 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in M.D.C. by 1.6% in the 4th quarter. Bank of New York Mellon Corp now owns 1,008,669 shares of the construction company’s stock worth $32,156,000 after purchasing an additional 15,705 shares in the last quarter. Institutional investors own 94.24% of the company’s stock.

A number of brokerages have recently issued reports on MDC. Zacks Investment Research raised shares of M.D.C. from a “hold” rating to a “strong-buy” rating and set a $38.00 price objective on the stock in a research report on Thursday, February 1st. Raymond James Financial raised shares of M.D.C. from a “market perform” rating to an “outperform” rating and set a $35.00 price objective on the stock in a research report on Tuesday, February 13th. They noted that the move was a valuation call. UBS Group raised shares of M.D.C. from a “sell” rating to a “buy” rating and set a $32.00 price objective on the stock in a research report on Tuesday. ValuEngine downgraded shares of M.D.C. from a “buy” rating to a “hold” rating in a research report on Thursday, March 1st. Finally, Bank of America lifted their price objective on shares of M.D.C. from $31.00 to $34.00 and gave the stock an “underperform” rating in a research report on Friday, February 2nd. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the stock. M.D.C. has an average rating of “Hold” and a consensus price target of $33.71.

WARNING: This article was reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://www.dailypolitical.com/2018/03/14/m-d-c-holdings-inc-mdc-director-herbert-t-buchwald-sells-4644-shares.html.

About M.D.C.

M.DC Holdings, Inc is engaged in two primary operations, including homebuilding and financial services. The Company’s segments include West, including segments located in Arizona, California, Nevada and Washington; Mountain, including segments located in Colorado and Utah; East, including segments located in Virginia, Florida and Maryland, which includes Pennsylvania and New Jersey; mortgage operations, including HomeAmerican Mortgage Corporation, and Other, which includes Allegiant Insurance Company, Inc, StarAmerican Insurance Ltd., American Home Insurance Agency, Inc and American Home Title and Escrow Company.

Insider Buying and Selling by Quarter for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.